This Article is From Apr 29, 2021

"We Don't Have Vaccines": Delhi Ahead Of Big 18+ Inoculation Drive

Delhi Health Minister Satyendar Jain said the public will be informed when the stocks are replenished.

Delhi Health Minister Satyendar Jain has said fresh orders have been placed for the vaccines.

New Delhi:

Two days ahead of phase III of the national Covid vaccination drive, which will include all adults, the Delhi government today said the city had run out of doses. The administration now awaits fresh supplies from private companies, state Health Minister Satyendar Jain, adding that people will be informed when stocks are replenished.

"We don't have vaccines as of now. We have made requests to the company regarding vaccines, we will tell you when it comes," Mr Jain said. He also said the manufacturers are yet to provide a schedule of vaccine supply to the Delhi government.

Chief Minister Arvind Kejriwal, on Monday, had said that his government had approved the procurement of 1.34 crore vaccine doses from various manufacturers. He will hold a meeting with officials today to take stock of the situation in the national capital.

On Wednesday, Delhi recorded 25,296 new COVID-19 cases along with 368 deaths. Overall, it has recorded nearly 11 lakh infections and over 15,000 deaths. It was the seventh consecutive day that the national capital witnessed daily fatalities of over 300. The positivity rate in Delhi is 31.76 per cent and the case fatality rate is 1.4 per cent.

"In the last 1.5 months, the daily positivity (rate) had never been below the 10-day average, but it has been below for three days now. So we can see a ray of hope, it seems the positivity rate will gradually come down here," Mr Jain said.

The city has also borne the brunt of an acute resource shortage that has hit the country in recent weeks due to the overwhelming inflow of patients into hospitals.

Under the third phase of the vaccination drive, which is also dubbed "liberalised", vaccine makers will supply 50 per cent of their monthly Central Drugs Laboratory-released doses to the Government of India and will be allowed to supply the remaining half to state governments and in the open market.